New Biomarkers For Multiple Sclerosis Pathogenesis
http://neurosciencenews.com/multiple-scleosis-pathogensis-6730/

CCSVI Alliance asks: ....why not test for these biomarkers pre and post treatment (whether it be pharmaceutical, or other intervention including vascular) to measure change in level of CSF solutes?

Researchers identify new biomarkers associated with multiple sclerosis pathogenesis.